Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Renal Failure

Free Subscription Articles published in J Nephrol Retrieve available abstracts of 198 articles: HTML format

Single Articles

October 2025
1. PARIBELLO G, Papa F, Ganzerli MC, Pisani A, et al
   Semaglutide in overweight non-diabetic peritoneal dialysis patients: a real-world single-center experience.
   J Nephrol. 2025 Oct 8. doi: 10.1007/s40620-025-02453.
   PubMed    
   
   
   
2. MUSTAFA A, Yermekbay A, Zhankorazova A, Toktarbay B, et al
   Hemodynamic effects of hemodialysis: the interaction between the heart and the arteries.
   J Nephrol. 2025 Oct 7. doi: 10.1007/s40620-025-02434.
   PubMed     Abstract available
   
   
   
3. MAHIC O, van Lieshout TS, Abrahams AC, Driehuis E, et al
   Longitudinal associations between iron status and patient-reported outcomes in incident dialysis patients: a DOMESTICO substudy.
   J Nephrol. 2025 Oct 2. doi: 10.1007/s40620-025-02363.
   PubMed     Abstract available
   
   
   September 2025
4. OLSZEWSKI M, Bjurstrom K, Lingman M, Henrohn D, et al
   Differences in chronic kidney disease management based on identification and diagnosis in a population-based observational study.
   J Nephrol. 2025 Sep 26. doi: 10.1007/s40620-025-02414.
   PubMed     Abstract available
   
   
   
5. DIXON A, You Z, Richey R, Furgeson S, et al
   Effects of sodium bicarbonate therapy on cognitive function in chronic kidney disease (ancillary study): a randomized controlled trial.
   J Nephrol. 2025 Sep 25. doi: 10.1007/s40620-025-02429.
   PubMed    
   
   
   
6. KAMPMANN JD, Stel VS, Christensen LS, Kramer A, et al
   Socioeconomic factors and access to home dialysis and early kidney transplantation across Europe.
   J Nephrol. 2025 Sep 19. doi: 10.1007/s40620-025-02424.
   PubMed    
   
   
   
7. JAYOUSI S, Cinelli M, Bigazzi R, Bianchi S, et al
   Functionality and sustainability of telemedicine for home-based management of patients with chronic kidney disease: the telemechron study.
   J Nephrol. 2025 Sep 18. doi: 10.1007/s40620-025-02348.
   PubMed     Abstract available
   
   
   
8. RODRIGUES HCN, de Oliveira Sousa AG, Preto VRM, de Paula Cunha LN, et al
   Low physical function is a risk factor for mortality in non-dialysis-dependent chronic kidney disease patients.
   J Nephrol. 2025 Sep 15. doi: 10.1007/s40620-025-02420.
   PubMed    
   
   
   
9. LARKIN J, Ligabue G, Alfano G, Cadenas RM, et al
   A life cycle assessment of peritoneal dialysis procurement in Italy: environmental burden and opportunities for improvement.
   J Nephrol. 2025 Sep 15. doi: 10.1007/s40620-025-02409.
   PubMed     Abstract available
   
   
   
10. LOUTATI R, Copeland V, Klempfner R, Ben-Zekry S, et al
    The effect of chronic kidney disease on the association of tricuspid regurgitation with overall survival : Insights from SHEBAHEART big data.
    J Nephrol. 2025 Sep 15. doi: 10.1007/s40620-025-02377.
    PubMed     Abstract available
    
    
    
11. ZEILER M, Mancini A, Federico A, Ramazzotti V, et al
    Dynamic functional examination of the peritoneal dialysis catheter using color Doppler ultrasound. In vitro technical evaluation and in vivo application.
    J Nephrol. 2025 Sep 13. doi: 10.1007/s40620-025-02421.
    PubMed     Abstract available
    
    
    
12. SCHMILL P, Seaton N, Greenwood S, Hudson JL, et al
    Do psycho-behavioural interventions improve mental and physical health in chronic kidney disease? A systematic review of randomised controlled trials.
    J Nephrol. 2025 Sep 10. doi: 10.1007/s40620-025-02372.
    PubMed     Abstract available
    
    
    
13. MARCH DS, Bernhardt L, Barber K, Curtis F, et al
    Prevalence and characteristics of treatments for sleep disordered breathing in people receiving dialysis: a scoping review.
    J Nephrol. 2025 Sep 9. doi: 10.1007/s40620-025-02370.
    PubMed     Abstract available
    
    
    
14. FERIOZZI S, Battaglia Y, Cirami CL, Gangemi C, et al
    The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian Society of Nephrology.
    J Nephrol. 2025 Sep 8. doi: 10.1007/s40620-025-02406.
    PubMed     Abstract available
    
    
    
15. CHUANG GT, Hsiung CN, Che TP, Oh KH, et al
    Genome-wide polygenic risk score for estimated glomerular filtration slope predicts chronic kidney disease in a Taiwanese population.
    J Nephrol. 2025 Sep 4. doi: 10.1007/s40620-025-02380.
    PubMed     Abstract available
    
    
    
16. SUZUKI Y, Kamiya K, Hoshi K, Tanaka S, et al
    Effects of electrical muscle stimulation during hemodialysis in older patients with frailty: a crossover randomized controlled trial.
    J Nephrol. 2025 Sep 3. doi: 10.1007/s40620-025-02383.
    PubMed     Abstract available
    
    
    
17. SAWIRES H, Abdallah S, Ramadan M, Abdel-Halim R, et al
    Osteocalcin as a predictor of bone fracture in children with chronic kidney diseases.
    J Nephrol. 2025 Sep 3. doi: 10.1007/s40620-025-02385.
    PubMed     Abstract available
    
    
    
18. WANG X, He J, Wang Y
    Long-term outcomes following acute kidney injury in individuals with pre-existing chronic kidney disease: a systematic review and meta-analysis.
    J Nephrol. 2025 Sep 1. doi: 10.1007/s40620-025-02373.
    PubMed     Abstract available
    
    
    August 2025
19. VAN HOVE P, Vleut R, Ligthart S
    Hypertonic continuous venovenous hemodialysis managing nontraumatic subdural hematoma in a hemodialysis patient. A lesson for the clinical nephrologist.
    J Nephrol. 2025 Aug 28. doi: 10.1007/s40620-025-02344.
    PubMed    
    
    
    
20. JAQUES DA, Dufey A, Alves C, De Seigneux S, et al
    Importance of age and timing of referral when initiating dialysis.
    J Nephrol. 2025 Aug 26. doi: 10.1007/s40620-025-02390.
    PubMed     Abstract available
    
    
    
21. FERRARA P, Rozza D, Antonazzo IC, Zamparini M, et al
    Awareness and management of stage 3 chronic kidney disease among primary care practitioners in Italy: a nation-wide observational study.
    J Nephrol. 2025 Aug 24. doi: 10.1007/s40620-025-02384.
    PubMed     Abstract available
    
    
    
22. GHONEIM M, Davenport A
    Frailty compared to sarcopenia as the predictor of mortality for elderly hemodialysis patients.
    J Nephrol. 2025 Aug 21. doi: 10.1007/s40620-025-02368.
    PubMed     Abstract available
    
    
    
23. CAPELLI I, De Benedictis M, Di Lenarda A, Di Maso V, et al
    Optimizing urine albumin-to-creatinine ratio testing and referral pathways for chronic kidney disease: a nominal group technique consensus study among Italian experts.
    J Nephrol. 2025 Aug 20. doi: 10.1007/s40620-025-02371.
    PubMed     Abstract available
    
    
    
24. KANAKUBO Y, Inanaga R, Toida T, Aita T, et al
    Trust in physicians as a mediator of the relationship between person-centered care and medication adherence in patients undergoing hemodialysis: a cross-sectional study.
    J Nephrol. 2025 Aug 19. doi: 10.1007/s40620-025-02387.
    PubMed     Abstract available
    
    
    
25. GROBMAN B, Mansur A, Lu CY
    Social vulnerability and chronic kidney disease-associated mortality in the United States: 1999-2020.
    J Nephrol. 2025 Aug 4. doi: 10.1007/s40620-025-02369.
    PubMed     Abstract available
    
    
    July 2025
26. PARK SJ, Kim YN, Oh BK, Yu H, et al
    Efficacy and safety of antithrombotics in patients with atrial fibrillation undergoing hemodialysis: a nationwide cohort study in Korea.
    J Nephrol. 2025 Jul 31. doi: 10.1007/s40620-025-02340.
    PubMed     Abstract available
    
    
    
27. ZHAO L, Shang J, Shi Y, Yan Y, et al
    Quantifying ultrasound echogenicity difference for accurate chronic kidney disease diagnosis.
    J Nephrol. 2025 Jul 30. doi: 10.1007/s40620-025-02352.
    PubMed     Abstract available
    
    
    
28. YUN HR, Joo YS, Kim HW, Park JT, et al
    Type 2 diabetes mellitus modifies the relationship between coronary artery calcification and adverse kidney outcome in patients with chronic kidney disease: the findings from KNOW-CKD.
    J Nephrol. 2025 Jul 30. doi: 10.1007/s40620-025-02364.
    PubMed     Abstract available
    
    
    
29. KO B, Ko YE, Jung CY, Kang DH, et al
    Association of accelerometer-measured physical activity with adverse cardiovascular outcomes in individuals with or without chronic kidney diseases: the UK biobank study.
    J Nephrol. 2025 Jul 28. doi: 10.1007/s40620-025-02345.
    PubMed     Abstract available
    
    
    
30. PIVETEAU J, Bayat S, Vigneau C, Couchoud C, et al
    The evolution of consultation practices with general practitioners and nephrologists for patients with chronic kidney disease before and after the COVID-19 pandemic in France.
    J Nephrol. 2025 Jul 27. doi: 10.1007/s40620-025-02376.
    PubMed     Abstract available
    
    
    
31. HANNANE N, Mayer CC, Matschkal J, Bormann F, et al
    Long-term prediction of mortality by heart rate turbulence in hemodialysis patients and the impact of diabetes mellitus-a longitudinal observational study.
    J Nephrol. 2025 Jul 15. doi: 10.1007/s40620-025-02357.
    PubMed     Abstract available
    
    
    
32. LIGHTFOOT CJ, Wilkinson TJ, Graham-Brown MPM, Smith AC, et al
    Supporting people with chronic kidney disease to self-manage their condition: understanding the lived experiences, needs and requirements, and barriers and facilitators.
    J Nephrol. 2025 Jul 12. doi: 10.1007/s40620-025-02349.
    PubMed     Abstract available
    
    
    
33. KASRADZE T, Didbaridze T, Tchokhonelidze I
    Impact of sodium bicarbonate locking solution on catheter-related blood stream infection in hemodialysis patients: comparative effectiveness of three locks.
    J Nephrol. 2025 Jul 1. doi: 10.1007/s40620-025-02315.
    PubMed     Abstract available
    
    
    June 2025
34. PROUVOT J, Reboul P, Ahmadpoor P, Clemmer E, et al
    Performance of the Kidney Failure Risk Equation according to diabetic status in the CKD-CAREMEAU cohort of patients with chronic kidney disease.
    J Nephrol. 2025 Jun 19. doi: 10.1007/s40620-025-02286.
    PubMed     Abstract available
    
    
    
35. BEZERRA R, Feitosa ADM, Barbosa R, Aguiar FC, et al
    Assessing the reliability of self-reported home blood pressure measurements in dialysis patients.
    J Nephrol. 2025 Jun 10. doi: 10.1007/s40620-025-02324.
    PubMed    
    
    
    
36. MURASHIMA M, Fujii N, Goto S, Hasegawa T, et al
    Correction: Residual kidney function modifies the effect of cinacalcet on serum phosphorus levels among peritoneal dialysis patients.
    J Nephrol. 2025 Jun 10. doi: 10.1007/s40620-025-02333.
    PubMed    
    
    
    
37. CHA'ON U, Aranyapal A, Lertsinudom S, Japrung D, et al
    Prevalence and risk factors of chronic kidney disease of unknown etiology in Northeast Thailand.
    J Nephrol. 2025 Jun 10. doi: 10.1007/s40620-025-02302.
    PubMed     Abstract available
    
    
    
38. FERRARO PM, Arbustini E, Bellino D, Caletti C, et al
    Primary hyperoxaluria type 1 diagnosis in adult dialysis patients: prediction model assessment in a group of Italian patients.
    J Nephrol. 2025 Jun 4. doi: 10.1007/s40620-025-02243.
    PubMed     Abstract available
    
    
    
39. CALISKAN Y, Yildiz A, Aypek H, Oto OA, et al
    Comparative validation of the Mayo Clinic imaging classification and PROPKD score for predicting ADPKD progression across diverse ethnic cohorts.
    J Nephrol. 2025;38:1469-1477.
    PubMed     Abstract available
    
    
    May 2025
40. DONDJIO JEMELE LJ, Buzzi M, Petipa Nga O, Couchoud C, et al
    Oral health care among dialysis patients in France and impact on survival.
    J Nephrol. 2025 May 30. doi: 10.1007/s40620-025-02307.
    PubMed     Abstract available
    
    
    
41. TARRASS F, Benjelloun M, Razkaoui A, Benjelloun O, et al
    Sustainable reuse of hemodialysis reject water for potato farming: a large-scale feasibility study in Morocco.
    J Nephrol. 2025 May 23. doi: 10.1007/s40620-025-02295.
    PubMed     Abstract available
    
    
    
42. ALDER H, Gaspert A, Fuster DG
    Adenine phosphoribosyltransferase deficiency as a rare cause of rapidly progressive chronic kidney disease.
    J Nephrol. 2025 May 14. doi: 10.1007/s40620-025-02304.
    PubMed    
    
    
    
43. RAJAN AK, Khader NA, Poojari PG, Attur RP, et al
    Development, validation, and reliability of a questionnaire to assess risk-factors of chronic kidney disease of unknown etiology.
    J Nephrol. 2025 May 12. doi: 10.1007/s40620-025-02297.
    PubMed     Abstract available
    
    
    
44. BERTAZZA PARTIGIANI N, D'Uva A, Vigezzi S, Brazzale AR, et al
    Comparative efficacy of epoetin alfa vs. darbepoetin in children with chronic kidney disease: a systematic review, meta-analysis and cost-effectiveness analysis.
    J Nephrol. 2025 May 11. doi: 10.1007/s40620-025-02303.
    PubMed     Abstract available
    
    
    
45. MURAKAMI M, Aoki T, Sugiyama Y, Sasaki S, et al
    Association between primary care physician-nephrologist collaboration and clinical outcomes in patients with stage 5 chronic kidney disease: a JOINT-KD cohort study.
    J Nephrol. 2025 May 8. doi: 10.1007/s40620-025-02299.
    PubMed     Abstract available
    
    
    
46. ALFANO G, Albinelli A, Ferri C, Romaniello R, et al
    Migrants on hemodialysis (HD): clinical characteristics, outcome and quality of life.
    J Nephrol. 2025 May 6. doi: 10.1007/s40620-025-02281.
    PubMed     Abstract available
    
    
    April 2025
47. D'ALESSANDRO C, Giannese D, Piccoli GB, Panichi V, et al
    Ketogenic diets in chronic kidney disease patients: a review for skeptics by skeptics.
    J Nephrol. 2025 Apr 30. doi: 10.1007/s40620-025-02285.
    PubMed     Abstract available
    
    
    
48. PERROTTA AM, Piccoli GB, Di Giandomenico M, Rotondi S, et al
    Preliminary results of a questionnaire aimed at evaluating the carbon footprint of hemodialysis facilities.
    J Nephrol. 2025 Apr 29. doi: 10.1007/s40620-025-02301.
    PubMed    
    
    
    
49. CAMPO A, Goia F, Cottino R, Gandolfo C, et al
    Reduced intensity incremental hemodialysis start does not decrease life expectancy and saves money: results of the RIDDLE study.
    J Nephrol. 2025 Apr 23. doi: 10.1007/s40620-025-02271.
    PubMed     Abstract available
    
    
    
50. RAFFRAY M, Campeon A, Bricard D, Auge E, et al
    Learning from the implementation phase of the new French capitation payment model for chronic kidney disease care: a qualitative study.
    J Nephrol. 2025 Apr 22. doi: 10.1007/s40620-025-02284.
    PubMed     Abstract available
    
    
    
51. INNECCHI MLR, Avesani CM, Coelho VA, Lauar JC, et al
    Outpatient clinic for older patients with chronic kidney disease: a model of a multidisciplinary care model.
    J Nephrol. 2025 Apr 20. doi: 10.1007/s40620-025-02293.
    PubMed     Abstract available
    
    
    
52. MORI D, Hayashi M, Honda R, Tanoue H, et al
    Short-term prognostic score for very elderly patients, aged 85 or older, initiating hemodialysis.
    J Nephrol. 2025 Apr 15. doi: 10.1007/s40620-025-02292.
    PubMed     Abstract available
    
    
    
53. GRYCUK W, Jakubowska Z, Malyszko J
    Proenkephalin (PENK): a functional biomarker in chronic kidney diseases - hope or just a new bystander?
    J Nephrol. 2025 Apr 15. doi: 10.1007/s40620-025-02268.
    PubMed     Abstract available
    
    
    
54. CLAUSE AL, Dethier P, Piccoli GB, Gambino G, et al
    Pregnancy on short daily home hemodialysis using low flow dialysate. A narrative review of the literature and a new case report.
    J Nephrol. 2025 Apr 11. doi: 10.1007/s40620-025-02265.
    PubMed     Abstract available
    
    
    
55. HUH H, Han K, Kim M, Shin YS, et al
    Early-stage chronic kidney disease as a risk factor for suicide: a nationwide observational cohort study.
    J Nephrol. 2025 Apr 9. doi: 10.1007/s40620-025-02219.
    PubMed     Abstract available
    
    
    
56. RAJA N, Radhakrishnan H, Masilamani S, Jothy AA, et al
    Family Income and Employment Status Play an Important Role in The Quality of Life of Hemodialysis Patients in a Resource-Limited Setting.
    J Nephrol. 2025 Apr 5. doi: 10.1007/s40620-025-02254.
    PubMed     Abstract available
    
    
    
57. DAVY A, Oberg CM, Boyer A, Lanot A, et al
    Bimodal solutions in peritoneal dialysis: what can we expect from different glucose volumes added to the icodextrin bag? Data from a simulation procedure.
    J Nephrol. 2025 Apr 1. doi: 10.1007/s40620-025-02206.
    PubMed     Abstract available
    
    
    March 2025
58. SAKA Y, Naruse T, Katsurayama Y, Sato Y, et al
    Serum zinc level is associated with aortic arch calcification in incident dialysis patients.
    J Nephrol. 2025 Mar 29. doi: 10.1007/s40620-025-02283.
    PubMed     Abstract available
    
    
    
59. PONCE D, Bannwart J, Silva MZC, Zamoner W, et al
    Peritoneal dialysis in acute kidney injury: twenty years of experience at a single center in a developing country.
    J Nephrol. 2025 Mar 29. doi: 10.1007/s40620-024-02189.
    PubMed     Abstract available
    
    
    
60. TRAISE A, Dieberg G, Degotardi E, Hart B, et al
    The effect of exercise training on quality of life in people with chronic kidney disease requiring dialysis. A systematic review with meta-analysis.
    J Nephrol. 2025 Mar 28. doi: 10.1007/s40620-025-02245.
    PubMed     Abstract available
    
    
    
61. KAMEL NA, Stokes MA, Wright DFB, Sud K, et al
    Dosing practices, pharmacokinetics, and effectiveness of allopurinol in gout patients receiving dialysis: a scoping review.
    J Nephrol. 2025 Mar 25. doi: 10.1007/s40620-025-02269.
    PubMed     Abstract available
    
    
    
62. HUYNH DQ, Huynh HTT, Trieu NHK, Tran AH, et al
    Regional citrate anticoagulation for continuous renal replacement therapy: a prospective study in a resource-limited intensive care unit from Vietnam.
    J Nephrol. 2025 Mar 16. doi: 10.1007/s40620-025-02255.
    PubMed     Abstract available
    
    
    
63. YAVORSKIY P, Borrelli S, Esposito K, Maiorino MI, et al
    Lesson for the clinical nephrologist: glucagon-like peptide-1 receptor agonists (GLP-1 RA) in a patient with obesity and diabetic kidney disease on peritoneal dialysis.
    J Nephrol. 2025 Mar 14. doi: 10.1007/s40620-025-02247.
    PubMed    
    
    
    
64. MORISI N, Alfano G, Ferrarini M, Ferri C, et al
    Hemoadsorption and plasma adsorption: two current options for the 3rd dimension of dialysis purification.
    J Nephrol. 2025 Mar 12. doi: 10.1007/s40620-025-02257.
    PubMed     Abstract available
    
    
    
65. ZADEK F, Brunoni B, Mulazzani F, Sironi I, et al
    Acid-base implications of the Gibbs-Donnan effect during continuous veno-venous hemofiltration.
    J Nephrol. 2025 Mar 10. doi: 10.1007/s40620-025-02238.
    PubMed     Abstract available
    
    
    
66. GOK E, Sahin MK
    Chronic kidney disease awareness: a cross-sectional study in primary care settings in Turkiye.
    J Nephrol. 2025 Mar 8. doi: 10.1007/s40620-025-02210.
    PubMed     Abstract available
    
    
    
67. SHAILLY S, Hawkins J, Kirschner R, Naranjo FS, et al
    Lead intoxication in end-stage kidney disease: a lesson for the clinical nephrologist.
    J Nephrol. 2025 Mar 8. doi: 10.1007/s40620-025-02215.
    PubMed    
    
    
    
68. OKUBO A, Doi T, Morii K, Nishizawa Y, et al
    Predicting 3-year all-cause mortality in patients undergoing hemodialysis using machine learning.
    J Nephrol. 2025 Mar 6. doi: 10.1007/s40620-025-02236.
    PubMed     Abstract available
    
    
    
69. MALBERTI F, Possenti S, Pecchini P, Lucca B, et al
    Treatment of secondary hyperparathyroidism in hemodialysis patients: a comparison between two Italian centers to evaluate real-world guideline implementation.
    J Nephrol. 2025 Mar 5. doi: 10.1007/s40620-025-02227.
    PubMed     Abstract available
    
    
    
70. SCHMIDT R, Parravani A, Poling M, Diab A, et al
    Home dialysis as the incident modality in patients starting dialysis in West Virginia: role of the rural outreach kidney care clinic.
    J Nephrol. 2025 Mar 1. doi: 10.1007/s40620-025-02223.
    PubMed     Abstract available
    
    
    
71. MORI D, Tamai S, Nomi H, Nagatoya K, et al
    Effect of finerenone in patients with diabetes and advanced chronic kidney disease.
    J Nephrol. 2025 Mar 1. doi: 10.1007/s40620-025-02244.
    PubMed    
    
    
    
72. MANNAN F, Chinnadurai R, Wiltshire R, Hansel J, et al
    Epidemiology and early predictors of Fabry nephropathy: evaluation of long-term outcomes from a national Fabry centre.
    J Nephrol. 2025;38:579-587.
    PubMed     Abstract available
    
    
    February 2025
73. FABBRINI P, Pieruzzi F, Bellocchio F, Casana Eslava R, et al
    The prognostic reasoning system for chronic kidney disease progression (PROGRES-CKD) may help improve waiting list management for outpatient nephrology services in a second-level public hospital in Italy.
    J Nephrol. 2025 Feb 27. doi: 10.1007/s40620-025-02222.
    PubMed     Abstract available
    
    
    
74. UTHAYARAJAN N, Jayawardene KLTD, Weerasekara I
    Quality and sources of food and water consumed by people with chronic kidney disease of unknown etiology in Sri Lanka: a systematic review.
    J Nephrol. 2025 Feb 26. doi: 10.1007/s40620-024-02174.
    PubMed     Abstract available
    
    
    
75. MARXER CA, Paik JM, Zhuo M, Desai RJ, et al
    Changes in serum creatinine during and after pregnancy in female patients with or without chronic kidney disease: an observational study in UK primary care data.
    J Nephrol. 2025 Feb 26. doi: 10.1007/s40620-025-02208.
    PubMed    
    
    
    
76. WANG T, Goh JX, Seth S, Do LL, et al
    Chronic kidney disease-associated pruritus and patient-centred outcomes: a systematic review.
    J Nephrol. 2025 Feb 25. doi: 10.1007/s40620-025-02221.
    PubMed     Abstract available
    
    
    
77. KOBAYASHI D, Ganse M, Shinoda T, Hamada C, et al
    A survey on the association between patient activation and quality of life among patients with chronic kidney disease in Japan.
    J Nephrol. 2025 Feb 24. doi: 10.1007/s40620-025-02235.
    PubMed     Abstract available
    
    
    
78. CAROLLO C, Mancia E, Sorce A, Altieri C, et al
    Prognostic impact of neutrophil-to-lymphocyte ratio and vascular access in patients on chronic hemodialysis.
    J Nephrol. 2025 Feb 17. doi: 10.1007/s40620-024-02203.
    PubMed     Abstract available
    
    
    
79. HAN J, Zhang H, Li X, Tang Y, et al
    Relationship between dietary consumption of live microbes with mortality in adults with chronic kidney disease.
    J Nephrol. 2025 Feb 12. doi: 10.1007/s40620-025-02212.
    PubMed     Abstract available
    
    
    
80. CHU G, Matricciani L, Russo S, Viecelli AK, et al
    Sleep disturbances in adults with chronic kidney disease: an umbrella review.
    J Nephrol. 2025 Feb 8. doi: 10.1007/s40620-025-02214.
    PubMed     Abstract available
    
    
    
81. KOSMADAKIS G, Necoara A, Baudenon J, Deville C, et al
    Sleep disorders in hemodialysis patients.
    J Nephrol. 2025 Feb 7. doi: 10.1007/s40620-025-02229.
    PubMed    
    
    
    
82. HUSEYNLI B, Akkuzu E, Buyukkaragoz B, Bakkaloglu SA, et al
    Hyperammonemic encephalopathy requiring hemodialysis in a child with distal renal tubular acidosis.
    J Nephrol. 2025 Feb 7. doi: 10.1007/s40620-025-02218.
    PubMed     Abstract available
    
    
    
83. ANKAWI G
    Nurses' knowledge and perspectives on pregnancy among dialysis patients.
    J Nephrol. 2025 Feb 5. doi: 10.1007/s40620-025-02232.
    PubMed     Abstract available
    
    
    
84. KARUR AK, Kumar P, Nayak-Rao S
    Lessons for the clinical nephrologist: a rare presentation of extrapulmonary tuberculosis in a hemodialysis patient.
    J Nephrol. 2025 Feb 4. doi: 10.1007/s40620-024-02183.
    PubMed    
    
    
    
85. DI MARIO F, Regolisti G, Fani F, Menegazzo B, et al
    Sustained Low-Efficiency Dialysis (SLED) with Regional Citrate Anticoagulation (RCA) and new dialysis equipment: a prospective study with serum citrate measurements and electrolyte monitoring.
    J Nephrol. 2025 Feb 1. doi: 10.1007/s40620-024-02201.
    PubMed     Abstract available
    
    
    January 2025
86. MISHRA SR, Mehata S, Khanal V, Shrestha N, et al
    Tackling chronic kidney disease in Nepal: from evidence to action.
    J Nephrol. 2025 Jan 29. doi: 10.1007/s40620-024-02200.
    PubMed     Abstract available
    
    
    
87. YAJIMA T, Arao M
    Psoas muscle gauge and adverse clinical outcomes in patients on hemodialysis.
    J Nephrol. 2025 Jan 28. doi: 10.1007/s40620-024-02191.
    PubMed     Abstract available
    
    
    
88. COOPER AL, Panizza N, Bartlett R, Martin-Robins D, et al
    A period prevalence study of palliative care need and provision in adult patients attending hospital-based dialysis units.
    J Nephrol. 2025 Jan 27. doi: 10.1007/s40620-024-02193.
    PubMed     Abstract available
    
    
    
89. CHOI C, Kim MG, Kim JH
    Reno-protective effects of xanthine oxidase inhibitors in patients with type 2 diabetes and chronic kidney disease: a systematic review and meta-analysis.
    J Nephrol. 2025 Jan 27. doi: 10.1007/s40620-024-02199.
    PubMed     Abstract available
    
    
    
90. TAKAHASHI R, Yabe H, Ishikawa H, Hibino T, et al
    Effectiveness of rehabilitation in hospitalized hemodialysis patients as compared with rehabilitation in hospitalized patients not on hemodialysis: a retrospective cohort study.
    J Nephrol. 2025 Jan 23. doi: 10.1007/s40620-024-02192.
    PubMed     Abstract available
    
    
    
91. LACAVE F, Dufour I, Jamar F, Goffin E, et al
    An unexpected cause of dyspnea in a peritoneal dialysis patient: the hidden connection.
    J Nephrol. 2025 Jan 14. doi: 10.1007/s40620-024-02132.
    PubMed    
    
    
    
92. BISWAS P, Sahu AK, Sahoo SK, Ahmed SN, et al
    Prevalence of chronic kidney disease and anemia in Hirakud Command Area, Odisha, India: unveiling the role of environmental toxicants.
    J Nephrol. 2025 Jan 12. doi: 10.1007/s40620-024-02169.
    PubMed     Abstract available
    
    
    
93. STEVEN M, Reboul P, Gerbal M, Moranne O, et al
    Early diagnosis of tuberculous peritonitis after starting peritoneal dialysis.
    J Nephrol. 2025 Jan 9. doi: 10.1007/s40620-024-02190.
    PubMed    
    
    
    
94. MOUHEB A, Lambert O, Alencar de Pinho N, Jacquelinet C, et al
    Association between urate-lowering therapy and kidney failure in patients with chronic kidney disease.
    J Nephrol. 2025 Jan 8. doi: 10.1007/s40620-024-02179.
    PubMed     Abstract available
    
    
    
95. GU JH, Chonchol M, Hoffman C, Miyazaki M, et al
    Deoxycholic acid and the risk of death and cardiovascular events among patients with advanced chronic kidney disease.
    J Nephrol. 2025 Jan 3. doi: 10.1007/s40620-024-02185.
    PubMed    
    
    
    December 2024
96. ROSTOKER G, Rouanet S, Merzoug M, Chakaroun H, et al
    mRNA vaccine against SARS-CoV-2 response is comparable between patients on dialysis and healthy controls after adjustment for age, gender and history of COVID-19 infection.
    J Nephrol. 2024 Dec 20. doi: 10.1007/s40620-024-02161.
    PubMed    
    
    
    
97. MACIAS-CERVANTES HE, Ocampo-Apolonio MA, Guardado-Mendoza R, Baron-Manzo M, et al
    Effect of vitamin K1 supplementation on coronary calcifications in hemodialysis patients: a randomized controlled trial.
    J Nephrol. 2024 Dec 16. doi: 10.1007/s40620-024-02154.
    PubMed     Abstract available
    
    
    
98. MICHON-COLIN A, Lombardi Y, Seret G, Lavainne F, et al
    Impact of iron and erythropoiesis-stimulating agent dose on mortality of hemodialysis patients with cancer.
    J Nephrol. 2024 Dec 15. doi: 10.1007/s40620-024-02162.
    PubMed    
    
    
    
99. ZAIDAN N, Jalloul Y, Goldfarb DS, Azar H, et al
    Opioid use and poisoning in hospitalized patients with chronic kidney disease.
    J Nephrol. 2024 Dec 1. doi: 10.1007/s40620-024-02159.
    PubMed     Abstract available
    
    
    November 2024
100. CALDERON MARTINEZ E, Sanchez Cruz C, Diarte Acosta EY, Aguirre Cano DA, et al
     Efficacy and safety of novel anticoagulant therapies in patients with chronic kidney disease-a systematic review and meta-analysis.
     J Nephrol. 2024 Nov 29. doi: 10.1007/s40620-024-02130.
     PubMed     Abstract available
     
     
     
101. NAKANO Y, Mandai S, Mori Y, Ando F, et al
     Nationwide mortality following acute type B aortic dissection and the survival advantage of obesity among dialysis patients in Japan.
     J Nephrol. 2024 Nov 27. doi: 10.1007/s40620-024-02147.
     PubMed     Abstract available
     
     
     
102. BARBIERI G, Cazzoletti L, Melotti R, Hantikainen E, et al
     Development and evaluation of a kidney health questionnaire and estimates of chronic kidney disease prevalence in the Cooperative Health Research in South Tyrol (CHRIS) study.
     J Nephrol. 2024 Nov 27. doi: 10.1007/s40620-024-02157.
     PubMed     Abstract available
     
     
     
103. WALLEZ T, Fernandes G, Dragean CA, Moryoussef M, et al
     Computed tomography peritoneography to explore peritoneal dialysis dysfunction: a Nephrology picture.
     J Nephrol. 2024 Nov 25. doi: 10.1007/s40620-024-02155.
     PubMed    
     
     
     
104. PORTA DJ, Carrillo MN, Perez HA, Rivoira MA, et al
     Assessment of total carotid plaque area progression in patients with chronic kidney disease. Good practices for decision-making.
     J Nephrol. 2024 Nov 23. doi: 10.1007/s40620-024-02146.
     PubMed     Abstract available
     
     
     
105. YANG M, Liu X, Chen Y, Chen X, et al
     Validation and modification of renal risk score for prediction of long-term kidney survival in patients with MPO-ANCA-associated glomerulonephritis.
     J Nephrol. 2024 Nov 22. doi: 10.1007/s40620-024-02134.
     PubMed     Abstract available
     
     
     
106. RICCI L, Couchoud C, Carvalho A, Buzzi M, et al
     A feasibility study for understanding the demand and acceptability of a systematic symptom monitoring process in end-stage kidney disease.
     J Nephrol. 2024 Nov 21. doi: 10.1007/s40620-024-02153.
     PubMed    
     
     
     
107. BOLD E, Richardson KL, Al-Uzri A, Craven SF, et al
     Internet use and health literacy among pediatric chronic kidney disease patients and their caregivers.
     J Nephrol. 2024 Nov 18. doi: 10.1007/s40620-024-02136.
     PubMed     Abstract available
     
     
     
108. MANENTI L, Marcellusi A, Di Brino E, Aiello A, et al
     Cost effectiveness of difelikefalin for the treatment of patients with chronic kidney disease-associated pruritus undergoing hemodialysis in Italy.
     J Nephrol. 2024 Nov 8. doi: 10.1007/s40620-024-02144.
     PubMed     Abstract available
     
     
     
109. DOGAN O, Acar AGT, Gul M, Safak O, et al
     Predictors of acute kidney injury in chronic kidney disease patients treated for cardiovascular disease in the cardiac intensive care unit (MORCOR-TURK subgroup analysis).
     J Nephrol. 2024 Nov 8. doi: 10.1007/s40620-024-02127.
     PubMed     Abstract available
     
     
     
110. CATON E, Aird R, Da Silva-Gane M, Sridharan S, et al
     Communicating health risk in chronic kidney disease: a scoping review.
     J Nephrol. 2024 Nov 8. doi: 10.1007/s40620-024-02098.
     PubMed     Abstract available
     
     
     
111. DE NICOLA L, Cupisti A, D'Alessandro C, Gesualdo L, et al
     Integrating the new pharmacological standard of care with traditional nutritional interventions in non-dialysis CKD.
     J Nephrol. 2024 Nov 7. doi: 10.1007/s40620-024-02135.
     PubMed     Abstract available
     
     
     
112. COGLEY C, Smith-Jones M, Ralston ER, Bramham J, et al
     Premature mortality and disparities in kidney healthcare for people with chronic kidney disease and severe mental health difficulties.
     J Nephrol. 2024 Nov 2. doi: 10.1007/s40620-024-02103.
     PubMed     Abstract available
     
     
     
113. LI M, Chang D, Zhao Y, Wu L, et al
     Urinary renal tubular epithelial cells and casts as predictors of renal outcomes in patients with biopsy-proven diabetic nephropathy.
     J Nephrol. 2024;37:2233-2242.
     PubMed     Abstract available
     
     
     October 2024
114. KIM SE, Jung SH, Yang J, Kim H, et al
     Association between urine creatinine excretion and bone mineral density in chronic kidney disease: Results from the KNOW-CKD study.
     J Nephrol. 2024 Oct 29. doi: 10.1007/s40620-024-02123.
     PubMed     Abstract available
     
     
     
115. SANTOS GPA, Sesso R, Lugon JR, de Menezes Neves PDM, et al
     Geographic inequities in hemodialysis access: a call to reassess dialysis facility locations in Brazil.
     J Nephrol. 2024 Oct 25. doi: 10.1007/s40620-024-02120.
     PubMed     Abstract available
     
     
     
116. KANBAY M, Copur S, Yilmaz ZY, Mallamaci F, et al
     Ziltivekimab for anemia and atherosclerosis in chronic kidney disease: a new hope?
     J Nephrol. 2024 Oct 25. doi: 10.1007/s40620-024-02117.
     PubMed     Abstract available
     
     
     
117. TRAISE A, Dieberg G, Pearson MJ, Smart NA, et al
     The effect of exercise training in people with pre-dialysis chronic kidney disease: a systematic review with meta-analysis.
     J Nephrol. 2024 Oct 17. doi: 10.1007/s40620-024-02081.
     PubMed     Abstract available
     
     
     
118. CHO S, Kim M, Jung S, Cho JM, et al
     Potential benefits of hormone replacement therapy on cardiovascular and kidney outcomes in postmenopausal women with chronic kidney disease.
     J Nephrol. 2024 Oct 16. doi: 10.1007/s40620-024-02099.
     PubMed     Abstract available
     
     
     
119. PIROVANO M, Ganini C, Gallieni M, Porta C, et al
     Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology.
     J Nephrol. 2024 Oct 15. doi: 10.1007/s40620-024-02102.
     PubMed     Abstract available
     
     
     
120. BOONSTRA MD, do Amaral MSG, Navis G, Stegmann ME, et al
     Effectiveness of a health literacy intervention targeting both chronic kidney disease patients and health care professionals in primary and secondary care: a quasi-experimental study.
     J Nephrol. 2024 Oct 4. doi: 10.1007/s40620-024-02058.
     PubMed     Abstract available
     
     
     
121. AVESANI CM, Garcia-Testal A, Mesa-Gresa P, Marin AE, et al
     Peer-to-peer training among health care professionals working in dialysis clinics: an education approach from the GoodRENal project.
     J Nephrol. 2024 Oct 1. doi: 10.1007/s40620-024-02074.
     PubMed     Abstract available
     
     
     September 2024
122. CHEN CH, Tsai PH, Tsai WC, Ko MJ, et al
     Efficacy and safety of ketoanalogue supplementation combined with protein-restricted diets in advanced chronic kidney disease: a systematic review and meta-analysis.
     J Nephrol. 2024 Sep 28. doi: 10.1007/s40620-024-02065.
     PubMed     Abstract available
     
     
     
123. KANBAY M, Mizrak B, Copur S, Basile C, et al
     Cognitive impairment in patients on dialysis: can we prevent it?
     J Nephrol. 2024 Sep 21. doi: 10.1007/s40620-024-02093.
     PubMed     Abstract available
     
     
     
124. LEUNG KC, Mahony S, Brown EA, Corbett RW, et al
     Factors affecting intraperitoneal pressure (IPP) and its prognostic value in predicting leak risk and gastrointestinal symptoms in adult peritoneal dialysis patients: a systematic review and meta-analysis.
     J Nephrol. 2024 Sep 16. doi: 10.1007/s40620-024-02091.
     PubMed     Abstract available
     
     
     
125. WANG Z, Ma X, Li S, Pei H, et al
     Association between serum potassium, risk and prognosis of peritonitis in peritoneal dialysis patients - results from the Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study.
     J Nephrol. 2024 Sep 15. doi: 10.1007/s40620-024-02056.
     PubMed     Abstract available
     
     
     
126. WU Y, Xu X, Wenxiang Q, Dong J, et al
     Coping model, personality traits, social support and clinical outcomes in patients undergoing continuous ambulatory peritoneal dialysis: a post-hoc analysis of a randomized trial.
     J Nephrol. 2024 Sep 14. doi: 10.1007/s40620-024-02090.
     PubMed     Abstract available
     
     
     
127. VRDOLJAK I, Pozaic A, Bituh M, Leko N, et al
     Education and cooking methods in the management of calcium and PTH serum levels in patients on hemodialysis: a randomized controlled study.
     J Nephrol. 2024 Sep 13. doi: 10.1007/s40620-024-02024.
     PubMed     Abstract available
     
     
     
128. CHIMENTI G, Magli A, Spanu G, Santagati G, et al
     Visual supports and informative material not to forget counselling on reproductive health in dialysis: a point of view.
     J Nephrol. 2024 Sep 13. doi: 10.1007/s40620-024-02059.
     PubMed     Abstract available
     
     
     
129. BATTAGLIA Y, Baciga F, Bulighin F, Amicone M, et al
     Physical activity and exercise in chronic kidney disease: consensus statements from the Physical Exercise Working Group of the Italian Society of Nephrology.
     J Nephrol. 2024 Sep 13. doi: 10.1007/s40620-024-02049.
     PubMed     Abstract available
     
     
     
130. MILOVANOVA LY, Nezhdanov KS, Milovanova SY, Lebedeva MV, et al
     alpha-Klotho is associated with cardiovascular and all-cause mortality in patients with stage 3b and 4 chronic kidney disease (CKD): a long-term prospective cohort study.
     J Nephrol. 2024 Sep 2. doi: 10.1007/s40620-024-02069.
     PubMed     Abstract available
     
     
     
131. ALFIERI C, Molinari P, Vettoretti S, Fusaro M, et al
     Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation.
     J Nephrol. 2024 Sep 2. doi: 10.1007/s40620-024-02055.
     PubMed     Abstract available
     
     
     
132. LOMBARDI G, Votrico V, Ferraro PM, Tassi S, et al
     Intradialytic serum phosphate variations are associated with low PTH levels.
     J Nephrol. 2024;37:1911-1919.
     PubMed     Abstract available
     
     
     
133. PANICHI V, Rosati A, Mangione EA, Incognito F, et al
     Serum alkaline phosphatase is a strong predictor of mortality in ESKD patients: analysis of the RISCAVID cohort.
     J Nephrol. 2024;37:1843-1851.
     PubMed     Abstract available
     
     
     
134. BUTT U, Davenport A, Sridharan S, Farrington K, et al
     A practical approach to implementing incremental haemodialysis.
     J Nephrol. 2024;37:1791-1799.
     PubMed     Abstract available
     
     
     August 2024
135. KINPAYOM P, Banjongjit A, Towannang P, Rerknimitr R, et al
     Salvaging intraluminal peritoneal dialysis catheter obstruction from blood clot with a targeted thrombolytic agent: an innovation.
     J Nephrol. 2024 Aug 30. doi: 10.1007/s40620-024-02075.
     PubMed     Abstract available
     
     
     
136. DONATO B, Almeida R, Raimundo M, Velho S, et al
     Myosteatosis: an underrecognized risk factor for mortality in non-dialysis chronic kidney disease patients.
     J Nephrol. 2024 Aug 12. doi: 10.1007/s40620-024-02042.
     PubMed     Abstract available
     
     
     
137. PANUCCIO VA, Tripepi R, Versace MC, Russo D, et al
     Dialysis after contrast agent administration in patients on chronic hemodialysis: do all Italian nephrologists think the same way?
     J Nephrol. 2024 Aug 9. doi: 10.1007/s40620-024-01999.
     PubMed    
     
     
     
138. BOLIGNANO D, Greco M, Presta P, Duni A, et al
     Unbalanced circulating Humanin levels and cardiovascular risk in chronic hemodialysis patients: a pilot, prospective study.
     J Nephrol. 2024 Aug 5. doi: 10.1007/s40620-024-02032.
     PubMed     Abstract available
     
     
     July 2024
139. FUJIIKE DT, Santos LL, Silveira de Andrade L, Meneses GC, et al
     Endothelium-related biomarkers, hyperphosphatemia and mortality in hemodialysis patients: a moderation analysis.
     J Nephrol. 2024 Jul 31. doi: 10.1007/s40620-024-02033.
     PubMed    
     
     
     
140. MANSUR A, Grobman B, Lu CY
     Suicide among patients with chronic kidney disease in the United States: 1999-2020.
     J Nephrol. 2024 Jul 31. doi: 10.1007/s40620-024-02016.
     PubMed    
     
     
     
141. LI J, Liu J, Chen P, Ma H, et al
     Cluster analysis-based classification of fatigue in stable maintenance hemodialysis patients: a prospective cohort study.
     J Nephrol. 2024 Jul 30. doi: 10.1007/s40620-024-02037.
     PubMed     Abstract available
     
     
     
142. TORREGGIANI M, Esposito C
     Vascular access in incremental hemodialysis: is less always more?
     J Nephrol. 2024 Jul 29. doi: 10.1007/s40620-024-02021.
     PubMed    
     
     
     
143. PAOLA N
     Ethical and legal aspects of end of life in dialysis patients: an Italian point of view.
     J Nephrol. 2024 Jul 29. doi: 10.1007/s40620-024-01996.
     PubMed     Abstract available
     
     
     
144. KHALIL MA, Kasem MF, El-Hakim IZ, Abd Elhafez AM, et al
     Key performance indicators for monitoring of anemia management and iron status in children attending a pediatric dialysis unit: the experience of Ain Shams University.
     J Nephrol. 2024 Jul 18. doi: 10.1007/s40620-024-02017.
     PubMed     Abstract available
     
     
     
145. MAMVEN M, Adejumo OA, Edeki IR, Oyedepo DS, et al
     Perspectives of relatives of patients with end-stage kidney disease on kidney sources, commercial kidney donation, and barriers to living kidney donation in Nigeria: a qualitative study.
     J Nephrol. 2024 Jul 16. doi: 10.1007/s40620-024-02019.
     PubMed     Abstract available
     
     
     
146. JAYOUSI S, Cinelli M, Bigazzi R, Bianchi S, et al
     Telemedicine for home-based management of patients with chronic kidney diseases and comorbidities in Tuscany North-west region: a pilot study protocol (telemechron study).
     J Nephrol. 2024 Jul 15. doi: 10.1007/s40620-024-02023.
     PubMed    
     
     
     
147. SANTORO A, Gibertoni D, Ambrosini A, De Ferrari ME, et al
     Correction to: Impact of pruritus in patients undergoing hemodialysis in Italy: a patient?based survey.
     J Nephrol. 2024 Jul 13. doi: 10.1007/s40620-024-02028.
     PubMed    
     
     
     
148. CHEN Y, Zhang M, Li Y, Xie Q, et al
     Retroperitoneal leakage as an important cause of acquired ultrafiltration decline in peritoneal dialysis: clinical characteristics and related risk factors.
     J Nephrol. 2024 Jul 13. doi: 10.1007/s40620-024-02009.
     PubMed     Abstract available
     
     
     
149. FEDELI U, Pierobon S, Grande E, Nordio M, et al
     Trends in chronic kidney disease-related mortality before and during the pandemic in Northeastern Italy.
     J Nephrol. 2024 Jul 13. doi: 10.1007/s40620-024-02020.
     PubMed    
     
     
     
150. DE MASI S, Da Cas R, Ippolito FM, Baglio G, et al
     Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study.
     J Nephrol. 2024 Jul 12. doi: 10.1007/s40620-024-02007.
     PubMed     Abstract available
     
     
     
151. PIROVANO M, Luciani A, Re Sarto GV, Bramati A, et al
     Osimertinib in a patient with end-stage kidney disease not on hemodialysis.
     J Nephrol. 2024 Jul 7. doi: 10.1007/s40620-024-02014.
     PubMed     Abstract available
     
     
     
152. TRAN DNT, Ducher M, Fouque D, Fauvel JP, et al
     External validation of a 2-year all-cause mortality prediction tool developed using machine learning in patients with stage 4-5 chronic kidney disease.
     J Nephrol. 2024 Jul 4. doi: 10.1007/s40620-024-02011.
     PubMed     Abstract available
     
     
     
153. ADEJUMO OA, Edeki IR, Sunday Oyedepo D, Falade J, et al
     Global prevalence of depression in chronic kidney disease: a systematic review and meta-analysis.
     J Nephrol. 2024 Jul 2. doi: 10.1007/s40620-024-01998.
     PubMed     Abstract available
     
     
     
154. LUKOMSKI L, Pisula J, Wagner T, Sabov A, et al
     First experiences with machine learning predictions of accelerated declining eGFR slope of living kidney donors 3 years after donation.
     J Nephrol. 2024;37:1631-1642.
     PubMed     Abstract available
     
     
     
155. MELLA A, Calvetti R, Barreca A, Congiu G, et al
     Kidney transplants from elderly donors: what we have learned 20 years after the Crystal City consensus criteria meeting.
     J Nephrol. 2024;37:1449-1461.
     PubMed     Abstract available
     
     
     June 2024
156. TSALOUCHOS A, Simone G, Dattolo PC, Toccafondi A, et al
     Multidisciplinary approach to advance care planning and directives in patients with end-stage renal disease: a point of view on patient-centered decision-making.
     J Nephrol. 2024 Jun 28. doi: 10.1007/s40620-024-02002.
     PubMed     Abstract available
     
     
     
157. NAKAI K, Nishino T, Kagimura T, Narita I, et al
     Impact of transferrin saturation on cardiovascular events in non-dialysis-dependent chronic kidney disease patients treated with darbepoetin alfa.
     J Nephrol. 2024 Jun 28. doi: 10.1007/s40620-024-02000.
     PubMed     Abstract available
     
     
     
158. CHITTINANDANA P, Gojaseni P, Chuasuwan A, Singprasert R, et al
     Major adverse kidney events in multidisciplinary chronic kidney disease care compared with usual outpatient care: a propensity score matched analysis.
     J Nephrol. 2024 Jun 28. doi: 10.1007/s40620-024-01994.
     PubMed     Abstract available
     
     
     
159. SANTORO A, Gibertoni D, Ambrosini A, De Ferrari ME, et al
     Impact of pruritus in patients undergoing hemodialysis in Italy: a patient-based survey.
     J Nephrol. 2024 Jun 24. doi: 10.1007/s40620-024-01983.
     PubMed     Abstract available
     
     
     
160. SIERRA A, Etcheverry B, Alvarez-Maestro M, Lopez JM, et al
     Management of deceased and living kidney donor with lithiasis: a multicenter retrospective study on behalf of the renal transplant group of the Spanish urological association.
     J Nephrol. 2024 Jun 22. doi: 10.1007/s40620-024-01960.
     PubMed     Abstract available
     
     
     
161. MACHADO FP, Vicari AR, Bauer AC
     Assessing the impact of positive cultures in preservation fluid on renal transplant outcomes: a scoping review.
     J Nephrol. 2024 Jun 13. doi: 10.1007/s40620-024-01972.
     PubMed     Abstract available
     
     
     
162. ERMAN HELPER O, Qasim H, Tiosano S, Abu-Amar N, et al
     Physical fitness is an independent predictor of chronic kidney disease development in apparently healthy individuals.
     J Nephrol. 2024 Jun 13. doi: 10.1007/s40620-024-01966.
     PubMed     Abstract available
     
     
     
163. FERNANDEZ LUCAS M, Piris Gonzalez M, Diaz Dominguez ME, Collado Alsina A, et al
     Incremental hemodialysis and vascular access complications: a 12-year experience in a hospital hemodialysis unit.
     J Nephrol. 2024 Jun 5. doi: 10.1007/s40620-024-01932.
     PubMed     Abstract available
     
     
     
164. PRZYGOCKA A, Magnoni G, Picotti M, Rapana R, et al
     Rare case of postherpetic abdominal pseudohernia in a patient on peritoneal dialysis.
     J Nephrol. 2024 Jun 5. doi: 10.1007/s40620-024-01954.
     PubMed     Abstract available
     
     
     
165. TSENG CH, Hu YA, Chen YT, Yu WC, et al
     Beyond prevalence: significance and differential impact of echocardiographic abnormalities in dialysis patients.
     J Nephrol. 2024 Jun 4. doi: 10.1007/s40620-024-01963.
     PubMed     Abstract available
     
     
     
166. TARRASS F, Benjelloun M, Piccoli GB
     Hemodialysis water reuse within a circular economy approach. What can we add to current knowledge? A point of view.
     J Nephrol. 2024 Jun 3. doi: 10.1007/s40620-024-01989.
     PubMed     Abstract available
     
     
     
167. BEAL F, Forrester N, Watson E, Williams M, et al
     A targeted gene panel illuminates pathogenesis in young people with unexplained kidney failure.
     J Nephrol. 2024;37:1273-1284.
     PubMed     Abstract available
     
     
     
168. MIAO J, Thongprayoon C, Craici IM, Cheungpasitporn W, et al
     How to improve ChatGPT performance for nephrologists: a technique guide.
     J Nephrol. 2024;37:1397-1403.
     PubMed     Abstract available
     
     
     May 2024
169. MORGANTI C, Di Motta T, Andreone A, Bedogni S, et al
     Use of drug-coated balloons in the percutaneous treatment of arteriovenous fistula stenosis has a time-dependent effect: a retrospective analysis from one dialysis center.
     J Nephrol. 2024 May 29. doi: 10.1007/s40620-024-01975.
     PubMed    
     
     
     
170. BEROS A, Sluyter J, Hughes A, Hametner B, et al
     Arterial stiffness and incident chronic kidney disease: a large population-based cohort study.
     J Nephrol. 2024 May 29. doi: 10.1007/s40620-024-01968.
     PubMed     Abstract available
     
     
     
171. MICHOU V, Nikodimopoulou M, Liakopoulos V, Anifanti M, et al
     Home-based tele-exercise training and physical activity during the COVID-19 pandemic in chronic kidney disease patients.
     J Nephrol. 2024 May 29. doi: 10.1007/s40620-024-01976.
     PubMed     Abstract available
     
     
     
172. CAUCHY L, Mousty E, Pageaux GP, Moranne O, et al
     Successful pregnancy after 10 consecutive failures in a liver transplant patient with advanced kidney failure.
     J Nephrol. 2024 May 15. doi: 10.1007/s40620-024-01936.
     PubMed     Abstract available
     
     
     
173. ATTINI R, Cabiddu G, Ciabatti F, Montersino B, et al
     Correction to: Chronic kidney disease, female infertility, and medically assisted reproduction: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology.
     J Nephrol. 2024 May 9. doi: 10.1007/s40620-024-01980.
     PubMed    
     
     
     
174. LOCATELLI F, Del Vecchio L, Esposito C, Gesualdo L, et al
     Consensus commentary and position of the Italian Society of Nephrology on KDIGO controversies conference on novel anemia therapies in chronic kidney disease.
     J Nephrol. 2024 May 6. doi: 10.1007/s40620-024-01937.
     PubMed     Abstract available
     
     
     
175. ZAPPULO F, Di Nunzio M, Donati G, Scrivo A, et al
     Vitamin E-coated membrane reversed itchy rash during hemodialysis.
     J Nephrol. 2024 May 2. doi: 10.1007/s40620-024-01941.
     PubMed    
     
     
     
176. ARDISSINO G, Cresseri D, Mancuso MC, Capone V, et al
     Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibition.
     J Nephrol. 2024;37:1017-1026.
     PubMed     Abstract available
     
     
     
177. CETINKAYA H, Gursu M, Yazici H, Cebeci E, et al
     Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?
     J Nephrol. 2024;37:923-932.
     PubMed     Abstract available
     
     
     April 2024
178. HU H, Chau PH, Choi EPH
     Physical activity, exercise habits and health-related quality of life in maintenance hemodialysis patients: a multicenter cross-sectional study.
     J Nephrol. 2024 Apr 24. doi: 10.1007/s40620-024-01935.
     PubMed     Abstract available
     
     
     
179. GENOVESI S, Bianchi S, Basile C
     Role of the left atrial appendage closure in preventing thromboembolism in atrial fibrillation: what is the importance for chronic kidney disease patients?
     J Nephrol. 2024 Apr 24. doi: 10.1007/s40620-024-01944.
     PubMed    
     
     
     
180. BOSSOLA M, Picconi B
     Uremic toxins and the brain in chronic kidney disease.
     J Nephrol. 2024 Apr 16. doi: 10.1007/s40620-024-01929.
     PubMed     Abstract available
     
     
     
181. NWANOSIKE EM, Merchant HA, Sunter W, Ansari MA, et al
     A real-world exploration into clinical outcomes of direct oral anticoagulant therapy in people with chronic kidney disease: a large hospital-based study.
     J Nephrol. 2024 Apr 2. doi: 10.1007/s40620-024-01930.
     PubMed     Abstract available
     
     
     
182. YU B, Atta MG, Brennan DC, Kant S, et al
     Outcomes and management of kidney transplant recipients with Fabry disease: a review.
     J Nephrol. 2024;37:561-571.
     PubMed     Abstract available
     
     
     March 2024
183. MAMBELLI E, Grandi F, Santoro A
     Comparison of blood volume biofeedback hemodialysis and conventional hemodialysis on cardiovascular stability and blood pressure control in hemodialysis patients: a systematic review and meta-analysis of randomized controlled trials.
     J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-023-01844.
     PubMed     Abstract available
     
     
     
184. RODRIGUES HCN, Sousa AGO, Preto VRM, Ferro CMB, et al
     FRAIL scale as a screening tool and a predictor of mortality in non-dialysis dependent patients.
     J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-024-01900.
     PubMed     Abstract available
     
     
     
185. MATSUNAMI M, Suzuki T, Suzuki K, Kuji H, et al
     Resuming automated peritoneal dialysis after laparoscopic peritoneal wall anchoring for peritoneal dialysis catheter fixation.
     J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01917.
     PubMed    
     
     
     
186. MA T, Li X, Hao J, Song D, et al
     The prognostic values of estimating intraperitoneal pressure in the occurrence of abdominal wall complications in peritoneal dialysis patients.
     J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01913.
     PubMed     Abstract available
     
     
     
187. SOEDA K, Komaba H, Nakagawa Y, Kawabata C, et al
     Association of serum sodium levels with fractures and mortality in patients undergoing maintenance hemodialysis.
     J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01904.
     PubMed     Abstract available
     
     
     
188. BAYKARA ULUSAN M, Meltem E, Mutlu IN, Ulusan K, et al
     The predictive value of systemic inflammatory markers in 902 patients with tunneled hemodialysis catheter.
     J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-023-01880.
     PubMed     Abstract available
     
     
     
189. CORTVRINDT C, Van Biesen W, Gambino G, Clause AL, et al
     Factors influencing renal replacement therapy modality choice from the nephrologist's perspective.
     J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01915.
     PubMed     Abstract available
     
     
     
190. QING X, Jiang J, Yuan C, Xie K, et al
     Temporal trends in prevalence and disability of chronic kidney disease caused by specific etiologies: an analysis of the Global Burden of Disease Study 2019.
     J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01914.
     PubMed     Abstract available
     
     
     
191. SIMHADRI PK, Vaitla PK, Marathi R, Khan A, et al
     Donor-transmitted cystinuria in a renal transplant recipient.
     J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-023-01877.
     PubMed     Abstract available
     
     
     
192. REN W, Sun J, Zhang L, He W, et al
     Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy.
     J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01893.
     PubMed     Abstract available
     
     
     
193. RECCHIA A, Casazza R, Cozzolino M, Rizzi B, et al
     Kidney supportive care for advanced chronic and end-stage kidney disease: a retrospective cohort study.
     J Nephrol. 2024 Mar 6. doi: 10.1007/s40620-023-01879.
     PubMed     Abstract available
     
     
     
194. ALFANO G, Bergesio F, Lombardi M, Piccoli GB, et al
     Eco-dialysis in Italy: where are we? National survey on the eco-sustainability of dialysis across Italian dialysis centers.
     J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01882.
     PubMed    
     
     
     
195. ROTHEM Y, Askenasy E, Siman-Tov M, Davidov Y, et al
     Elevated hemoglobin levels in renal transplant recipients with polycystic kidney disease versus other etiologies: exploring mechanisms and implications for outcomes.
     J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01868.
     PubMed     Abstract available
     
     
     
196. CHLOROGIANNIS DD, Bousi SE, Zachiotis M, Chlorogiannis A, et al
     Pre-operative ultrasound mapping before arteriovenous fistula formation: an updated systematic review and meta-analysis.
     J Nephrol. 2024;37:281-292.
     PubMed     Abstract available
     
     
     January 2024
197. FANELLI F, Falcone G, Gabbani G, Annese AL, et al
     Multidisciplinary working group: key role for percutaneous endovascular AV fistula program. Point of view.
     J Nephrol. 2024;37:215-219.
     PubMed     Abstract available
     
     
     
198. SAFDAR A, Akram W, Khan MA, Alvi MN, et al
     Comparison of Pakistani CKD-EPI, new Asian-modified CKD-EPI and revised Lund-Malmo study equations in a South Asian CKD population: a study from a Pakistani CKD cohort.
     J Nephrol. 2024;37:119-129.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.